Preeclampsia is associated with a decrease in plasma coenzyme Q10 levels

Free Radical Biology and Medicine

Volumn 35, Issue 11, 2003, Pages 1453-1456

  Teran, Enrique ^a   Racines Orbe, Marcia ^a   Vivero, Sandra ^a   Escudero, Carlos ^a   Molina, Gustavo ^b   Calle, Andres ^b  

^a UNIVERSIDAD CENTRAL DEL ECUADOR   (Ecuador)

^b Hospital Gineco Obstetrico Isidro Ayora   (Ecuador)

Author keywords

Coenzyme Q10; Free radicals; Oxidative stress; Preeclampsia; Pregnancy

Indexed keywords

UBIDECARENONE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0344875068     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.08.004     Document Type: Article

References (30)

1. Friedman S.A., Taylor R.N., Roberts J.M. Pathophysiology of pre-eclampsia. Clin. Perinatol. 4:1991;661-682.
2. Davidge S.T., Hubel C.A., Brayden R.D., Capeless E.C. McLaughlin, M K. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet. Gynecol. 79:1992;897-901.
3. Wang Y., Walsh S.W. Antioxidant activities and mRNA expression of SOD, catalase and glutathione peroxidase in normal and preeclamptic placentas. J. Soc. Gynecol. Invest. 3:1996;179-184.
4. Crane F.L. Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 20:2001;591-598.
5. Crane F.L., Navas P. The diversity of coenzyme Q function. Mol. Aspects Med. 18:1997;s1-s6.
6. Karlsson J., Diamant B., Edlund P.O., Lund B., Folkers K., Theorell H. Plasma ubiquinone, alpha-tocopherol and cholesterol in man. Int. J. Vitam. Nutr. Res. 62:1992;160-164.
7. Kaikkonen J., Tuomainen T.P., Nyyssonen K., Salonen J.T. Coenzyme Q10 absorption, antioxidative properties, determinants, and plasma levels . Free Radic. Res. 36:2002;389-397.
8. Langsjoen P., Langsjoen P., Willis R., Folkers K. Treatment of essential hypertension with coenzyme Q10. Mol. Aspects Med. 15:1994;S265-S272.
9. Folkers K., Osterborg A., Nylander M., Morita M., Mellstedt H. Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer. Biochem. Biophys. Res. Commun. 234:1997;296-299.
10. Bresolin N., Bet L., Binda A., Moggio M., Comi G., Nador F., Ferrante C., Carenzi A., Scarlato G. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10. Neurology. 38:1988;892-899.
11. Kagan V., Serbinova E.A., Koynova G.M., Kitanova S.A., Tyurin V., Stoytchev T.S., Quinn P.J., Packer L. Antioxidant action of ubiquinol homologues with different isoprenoid chain length in biomembranes. Free Radic. Biol. Med. 9:1990;117-126.
12. Kagan V., Arroyo A., Tyurin V., Tyurin Y., Villalba J., Navas P. Plasma membrane NADH-coenzyme Q0 reductase generates semiquione radicals and recycles vitamin E homologue in a superoxide-dependent reaction. FEBS Lett. 428:1998;43-46.
13. Dallner G., Appelkvist E.L., Ernster L. Distribution and redox state of ubiquinones in rat and human tissues. Arch. Biochem. Biophys. 295:1992;230-234.
14. Hanaki Y., Sugiyama S., Ozawa T., Ohno M. Ratio of low-density lipoprotein cholesterol to ubiquinone as a coronary risk factor. N. Engl. J. Med. 325:1991;814-815.
15. McDonnell M.G., Archbold G.P. Plasma ubiquinol/cholesterol ratios in patients with hyperlipidaemia, those with diabetes mellitus and in patients requiring dialysis. Clin. Chim. Acta. 253:1996;117-126.
16. Lagendijk J., Ubbink J.B., Vermaak W.J. Measurement of the ratio between the reduced and oxidized forms of coenzyme Q10 in human plasma as a possible marker of oxidative stress. J. Lipid Res. 37:1996;67-75.
17. Kaikkonen J., Nyyssonen K., Tuomainen T.-P., Ristonmaa U., Salonen J.T. Determinants of plasma coenzyme Q10 in humans. FEBS Lett. 443:1999;163-166.
18. Johansen K., Theorell H., Karlsson J., Diamant B., Folkers K. Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. Ann. Med. 23:1991;649-656.
19. Noia G., Littarru G.P., De Santis M., Oradei A., Mactromarino C., Trivellini C., Caruso A. Coenzyme Q10 in pregnancy. Fetal Diagn. Ther. 11:1996;264-270.
20. Noia G., Romano D., De Santis M., Mariorenzi S., Caruso S., Mancuso S. Coenzyme Q10 fetal plasma levels. Fetal Diagn. Ther. 13:1998;127-130.
21. Lopez-Jaramillo P., Narvaez M., Weigel R.M., Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br. J. Obstet. Gynaecol. 96:1989;648-655.
22. Teran E., Escudero C., Moya W., Flores M., Vallance P., Lopez-Jaramillo P. Elevated C-reactive protein and pro-inflammatory cytokines in Andean women with pre-eclampsia. Int. J. Gynecol. Obstet. 75:2001;243-249.
23. Yamamoto Y., Yamashita S. Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress. Mol. Aspects Med. 18:1997;s79-s84.
24. Potter J.M., Nestel P.J. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am. J. Obstet. Gynecol. 133:1979;165-170.
25. Gratacos E., Casals E., Sallehy C., Cararacj V., Alonso P., Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet. Gynecol. Scand. 75:1996;896-901.
26. Ware-Jauregui S., Sanchez S.E., Zhang C., Laraburre G., King I.B., Williams M.A. Plasma lipid concentrations in pre-eclamptic and normotensive Peruvian women. Int. J. Gynecol. Obstet. 67:1999;147-155.
27. Cadenas E. Basic mechanism of antioxidant activity. Biofactors. 6:1997;391-397.
28. Redman C.W.G. Current topic pre-eclampsia and the placenta . Placenta. 12:1991;301-308.
29. McCarty M.F. Coenzyme Q versus hypertension does CoQ decrease endothelial superoxide generation? Med. Hypotheses. 53:1999;300-304.
30. Teran E., Feelisch M., Sazanov L., Moncada S. Ubiquinone reacts with nitric oxide to prevent the activity of purified mitochondrial complex I. Moncada S., Lars G., Winklund P., Higgs E.A. Biology of nitric oxide part 7. 2000;7 Portland Press, London.